20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with dihydrotestosterone in 11 studies
Studies (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Trials (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Recent Studies (post-2010) (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Studies (dihydrotestosterone) | Trials (dihydrotestosterone) | Recent Studies (post-2010) (dihydrotestosterone) |
---|---|---|---|---|---|
640 | 13 | 233 | 9,325 | 307 | 1,517 |
Protein | Taxonomy | 20-hydroxy-5,8,11,14-eicosatetraenoic acid (IC50) | dihydrotestosterone (IC50) |
---|---|---|---|
Plasma kallikrein | Homo sapiens (human) | 0.0031 | |
Glucocorticoid receptor | Homo sapiens (human) | 0.54 | |
Sex hormone-binding globulin | Homo sapiens (human) | 0.0038 | |
Progesterone receptor | Oryctolagus cuniculus (rabbit) | 0.44 | |
Progesterone receptor | Homo sapiens (human) | 7.3 | |
Mineralocorticoid receptor | Homo sapiens (human) | 0.36 | |
Sex hormone-binding globulin | Rattus norvegicus (Norway rat) | 0.023 | |
Androgen receptor | Homo sapiens (human) | 0.0048 | |
Androgen receptor | Rattus norvegicus (Norway rat) | 0.4041 | |
Androgen receptor | Mus musculus (house mouse) | 0.001 | |
Mineralocorticoid receptor | Rattus norvegicus (Norway rat) | 2.1 | |
Testosterone 17-beta-dehydrogenase 3 | Homo sapiens (human) | 0.0026 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (45.45) | 29.6817 |
2010's | 6 (54.55) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adas, F; Breyer, MD; Capdevila, JH; Falck, JR; Holla, VR; Imig, JD; Keeney, DS; Kovacs, WJ; Magnuson, MA; Olsen, N; Price, E; Waterman, MR; Zhao, X | 1 |
Capdevila, JH; Marji, JS; Nakagawa, K; Schwartzman, ML; Waterman, MR | 1 |
Skott, O | 1 |
Lombard, JH; Roman, RJ | 1 |
Cheng, J; Deng, H; Ishizuka, T; Kemp, R; Nasjletti, A; Schwartzman, ML; Singh, H | 1 |
Cheng, J; Falck, JR; Gotlinger, KH; Jat, JL; Kelkar, M; Schwartzman, ML; Wu, CC; Zhang, FF; Zhang, Y | 1 |
Capdevila, JH; Cheng, J; Ding, Y; Falck, JR; Garcia, V; Gotlinger, K; Manthati, VL; Mei, S; Schwartzman, ML; Weidenhammer, A; Wu, CC; Zhang, F | 1 |
Capdevila, JH; Dimitrova, I; Ding, Y; Falck, JR; Garcia, V; Joseph, G; Manthati, VL; Schwartzman, ML; Weidenhammer, A; Wu, CC; Zhang, F | 1 |
Bernstein, KE; Capdevila, JH; Dakarapu, R; Ding, Y; Falck, JR; Garcia, V; Gotlinger, K; Joseph, G; Schwartzman, ML; Shkolnik, B; Zhang, FF | 1 |
Dalmasso, C; Maranon, R; Moulana, M; Patil, C; Reckelhoff, JF; Romero, DG | 1 |
Alvarez, E; Colombero, C; Mormandi, E; Nowicki, S; Papademetrio, D; Sacca, P | 1 |
1 review(s) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and dihydrotestosterone
Article | Year |
---|---|
Does 20-hydroxyeicosatetraenoic acid contribute to sex differences in cardiovascular risk by increasing oxidative stress?
Topics: Animals; Cardiovascular Diseases; Dihydrotestosterone; Endothelium, Vascular; Humans; Hydroxyeicosatetraenoic Acids; Hypertension; Oxidative Stress; Risk Factors; Sex Characteristics | 2007 |
10 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and dihydrotestosterone
Article | Year |
---|---|
Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension.
Topics: Androgens; Animals; Arachidonic Acid; Blood Pressure; Castration; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme System; Dihydrotestosterone; Enzyme Induction; Female; Gene Deletion; Hydroxyeicosatetraenoic Acids; Hypertension; Kidney; Male; Mice; Mice, Knockout; Microsomes; Mixed Function Oxygenases; Renal Circulation; RNA, Messenger; Sex Characteristics; Testosterone; Vascular Resistance | 2001 |
Androgen-mediated induction of the kidney arachidonate hydroxylases is associated with the development of hypertension.
Topics: Animals; Blood Pressure; Cells, Cultured; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 4; Dihydrotestosterone; Dose-Response Relationship, Drug; Enzyme Induction; Female; Hydroxyeicosatetraenoic Acids; Hypertension; Kidney; Liver; Male; Microsomes, Liver; Mixed Function Oxygenases; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sex Characteristics; Testosterone | 2003 |
Androgen-induced activation of 20-HETE production may contribute to gender differences in blood pressure regulation.
Topics: Animals; Blood Pressure; Dihydrotestosterone; Female; Gene Expression Regulation, Enzymologic; Humans; Hydroxyeicosatetraenoic Acids; Male; Rats; Sex Characteristics | 2003 |
Vascular cytochrome P450 4A expression and 20-hydroxyeicosatetraenoic acid synthesis contribute to endothelial dysfunction in androgen-induced hypertension.
Topics: Acetylcholine; Amidines; Animals; Blood Pressure; Cytochrome P-450 CYP4A; Dihydrotestosterone; Drug Synergism; Endothelium, Vascular; Hydroxyeicosatetraenoic Acids; Hypertension; Male; Membrane Glycoproteins; NADPH Oxidase 2; NADPH Oxidases; Oxidative Stress; Rats; Rats, Sprague-Dawley; Renal Artery; Superoxides; Vasodilation; Vasodilator Agents | 2007 |
Androgen-dependent hypertension is mediated by 20-hydroxy-5,8,11,14-eicosatetraenoic acid-induced vascular dysfunction: role of inhibitor of kappaB Kinase.
Topics: Androgens; Animals; Blood Pressure; Dihydrotestosterone; Endothelium, Vascular; Hydroxyeicosatetraenoic Acids; Hypertension; I-kappa B Kinase; Rats; Rats, Sprague-Dawley; Renal Artery; Sesquiterpenes; Vasoconstriction | 2011 |
Androgen-sensitive hypertension associates with upregulated vascular CYP4A12-20-HETE synthase.
Topics: Androgens; Animals; Blood Pressure; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 4; Dihydrotestosterone; Hydroxyeicosatetraenoic Acids; Hypertension; Kidney; Male; Mice; Up-Regulation | 2013 |
20-HETE induces remodeling of renal resistance arteries independent of blood pressure elevation in hypertension.
Topics: Animals; Blood Pressure; Dihydrotestosterone; Hydroxyeicosatetraenoic Acids; Hypertension; Male; Mice; Rats; Rats, Sprague-Dawley; Renal Artery; Reserpine | 2013 |
Angiotensin II receptor blockade or deletion of vascular endothelial ACE does not prevent vascular dysfunction and remodeling in 20-HETE-dependent hypertension.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Cytochrome P-450 Enzyme System; Dihydrotestosterone; Disease Models, Animal; Endothelial Cells; Endothelium, Vascular; Female; Hydroxyeicosatetraenoic Acids; Hypertension; Male; Mice, Transgenic; Microvessels; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Time Factors; Vascular Remodeling | 2015 |
20-HETE and CYP4A2 ω-hydroxylase contribute to the elevated blood pressure in hyperandrogenemic female rats.
Topics: Androgens; Animals; Body Weight; Cytochrome P-450 Enzyme System; Dihydrotestosterone; Female; Gene Deletion; Gene Knockout Techniques; Hydroxyeicosatetraenoic Acids; Hyperandrogenism; Hypertension; Microcirculation; Rats; Rats, Inbred Dahl; Renal Circulation; Steroids | 2016 |
Role of 20-Hydroxyeicosatetraenoic Acid (20-HETE) in Androgen-Mediated Cell Viability in Prostate Cancer Cells.
Topics: Androgens; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cytochrome P450 Family 4; Dihydrotestosterone; Gene Expression Regulation, Neoplastic; Humans; Hydroxyeicosatetraenoic Acids; Male; Prostatic Neoplasms; Receptors, Androgen | 2017 |